Psoriasis Treatment Market Rising psoriasis prevalence and increasing adoption of biologics are fueling strong growth in the global psorias ...

Bristol Myers' Cobenfy, the first new schizophrenia treatment in decades, shows early sales momentum and strong pipeline ...

Enanta Pharmaceuticals ( ($ENTA) ) has shared an announcement. On August 20, 2025, Enanta Pharmaceuticals announced it filed a patent infringement ...

New presbyopia-correcting eye drops, including VIZZ and Qlosi, offer alternatives to Vuity, with more options under FDA ...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

AbbVie’s ABBV stock has risen 11.5% in the past month, mainly due to its beat-and-raise performance in the second quarter.

Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd.

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...

Resmed has announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15. The company also announced that board member Rich Sulpizio is thanked for two decades of ...